Dr. Mansukh Mandaviya, Union Minister of Chemicals and Fertilizers and Health and Family Welfare, will launch the National Policy on Research and Development and Innovation in the Pharma-MedTech Sector in India and the Scheme for Promotion of...
Strides Pharma Science Limited (Strides) stated that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has acquired FDA approval for icosapent ethyl capsules 0.5 gram and 1 gram. The product is...
Jardiance (empagliflozin) 10 mg tablets have been approved by the US Food and Drug Administration (FDA) to reduce the risk of sustained decline in estimated glomerular filtration rate (eGFR), end-stage kidney disease, cardiovascular death, and...
ImageBiopsy Lab and Radiobotics have joined forces to improve the application of artificial intelligence (AI) enabled illness diagnoses in the DACH region for musculoskeletal (MSK), orthopaedic, and trauma use-cases. Musculoskeletal illnesses...
There has been a steady increase in the use of contract manufacturing companies since they play a crucial part in the creation of medications, nutritional supplements, and other pharmaceutical items.
Panolos Bioscience, a biopharmaceutical company focused on the development of multi-specific therapeutics to treat cancer, auto-immune diseases, and rare diseases, has formed a collaboration with Chime Biologics, a CDMO, for the development of...
The global Insulin Syringes Market is on the cusp of substantial growth, with projections indicating an impressive increase of $408.67 million during the period from 2022 to 2026. This growth trajectory is marked by a robust Compound Annual Growth...
Major pharmaceutical companies are increasingly turning to artificial intelligence (AI) to streamline patient selection for clinical trials and reduce the number of participants required, potentially speeding up drug development and saving signifi...
Glenmark Pharmaceuticals announced the sale of a 75% stake in its subsidiary company Glenmark Life Sciences to Nirma for $615 per share, for a total consideration of $5.651.75. With the equity reduction, the Mumbai-based drugmaker would retain...
In 2022, the worldwide antifibrinolytic medicines market is expected to be worth US$ 16.2 billion. In the future, it is predicted to rise to US$ 21.2 billion by 2028, with a compound annual growth rate (CAGR) of 4.5% from 2023 to...
, CDSCO.jpg)
.jpg)